“Sexual dimorphism in cancer”
About the meeting
Cancer susceptibility of individuals of different sex is significantly different in many cancer types and across ethnic backgrounds. The role of hormonal and genetic differences in in cancer susceptibility and response to treatment is still poorly understood. To meet this challenge, there is an urgent need to foster interdisciplinary cross-communication efforts and train the next generation of researchers in basic and translational cancer prevention.
The meeting will be an important first to meet these challenges and serve as paradigm for similar meetings to be held in the future. It will bring together and foster communication between young researchers and world experts from various disciplines, such as epidemiology, genetics and epigenetics, cellular and molecular biology, pharmacology and clinical oncology. As an integral part of the meeting, we encourage participation from members of the private industry sector, who can provide unique insights into translational applications and possible future developments.